Education
About Us
Working with TipRanks
Follow Us
Phreesia (PHR)
NYSE:PHR
PHR Analyst Ratings
Strong Buy
12 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
PHR Stock 12 Month Forecast
Average Price Target
$30.27
▲(88.72% Upside)
| Highest Price Target$35.00 | Average Price Target$30.27 | Lowest Price Target$25.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Truist Financial
$36→$29
Buy
80.80%
Upside
Reiterated
12/11/25
Robert W. Baird
$31→$25
Buy
55.86%
Upside
Reiterated
12/10/25
Mizuho Securities
$36→$28
Buy
74.56%
Upside
Reiterated
12/10/25
Canaccord Genuity
$38→$33
Buy
105.74%
Upside
Reiterated
12/09/25
J.P. Morgan
$32→$29
Buy
80.80%
Upside
Reiterated
12/09/25
William Blair
―
Buy
―
Reiterated
12/09/25
Citi
$34→$29
Buy
80.80%
Upside
Reiterated
12/09/25
D.A. Davidson
$35
Buy
118.20%
Upside
Reiterated
12/09/25
Needham
$35
Buy
118.20%
Upside
Reiterated
12/09/25
Phreesia's Strategic Growth and Financial Performance Drive Buy Rating Amid Attractive ValuationWe reiterate our Buy rating on PHR ahead of 3Q earnings. PHR is coming off a 2Q beat, where expense management led to another FY26 EBITDA raise, while the topline was reiterated. We expect the beat and EBITDA raise cadence to continue in 3Q, with a topline beat likely led by Network Solutions. With PHR's acquisition of 2Q call, we believe integration efforts and updates on realization of growth synergies will be in focus, particularly as it relates to new margin accretive growth and progress on moving core PHR upstream into AccessOne clients. Per usual, provider client adds, revenue per AHSC, and mix of organic/inorganic growth heading into FY27 will also be areas of focus on the call. With shares trading at 2.3x consensus FY27 rev. estimates, we believe the risk/reward remains attractive for investors at current levels.
Barclays
$26
Buy
62.09%
Upside
Initiated
12/08/25
BMO Capital
$32
Buy
99.50%
Upside
Assigned
12/02/25
KeyBanc
$35→$32
Buy
99.50%
Upside
Reiterated
10/08/25
Citizens JMP
$30→$34
Buy
111.97%
Upside
Reiterated
09/08/25
Raymond James
$30→$33
Buy
105.74%
Upside
Reiterated
09/05/25
Phreesia's Strong Financial Performance and Strategic Growth Initiatives Drive Buy RatingWe reiterate our Outperform rating and increase our price target to $33 (+$3) on shares of PHR following a modest beat in F2Q26, as the company reported revenue of $117.3M (Street: $116.5M, $116.3M) with strength across network solutions (+24.7% y/y), subscription (+10.5%) and payments (+12.2%). Adj. EBITDA of $22.1M was slightly above expectations (Street: $20.0M, $20.5M) benefiting from lower-than-expected S&M expense ($25.4M vs. $30.4M) and G&A ($19.0M vs. $19.4M), partially offset by higher R&D investment ($29.3M vs. $28.2M). Management reiterated its FY26 revenue outlook of $472–482M and raised its adj. EBITDA guide to $87–92M ($2M midpoint increase) reflecting continued operating leverage.
Piper Sandler
$33→$34
Buy
111.97%
Upside
Reiterated
09/05/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Truist Financial
$36→$29
Buy
80.80%
Upside
Reiterated
12/11/25
Robert W. Baird
$31→$25
Buy
55.86%
Upside
Reiterated
12/10/25
Mizuho Securities
$36→$28
Buy
74.56%
Upside
Reiterated
12/10/25
Canaccord Genuity
$38→$33
Buy
105.74%
Upside
Reiterated
12/09/25
J.P. Morgan
$32→$29
Buy
80.80%
Upside
Reiterated
12/09/25
William Blair
―
Buy
―
Reiterated
12/09/25
Citi
$34→$29
Buy
80.80%
Upside
Reiterated
12/09/25
D.A. Davidson
$35
Buy
118.20%
Upside
Reiterated
12/09/25
Needham
$35
Buy
118.20%
Upside
Reiterated
12/09/25
Phreesia's Strategic Growth and Financial Performance Drive Buy Rating Amid Attractive ValuationWe reiterate our Buy rating on PHR ahead of 3Q earnings. PHR is coming off a 2Q beat, where expense management led to another FY26 EBITDA raise, while the topline was reiterated. We expect the beat and EBITDA raise cadence to continue in 3Q, with a topline beat likely led by Network Solutions. With PHR's acquisition of 2Q call, we believe integration efforts and updates on realization of growth synergies will be in focus, particularly as it relates to new margin accretive growth and progress on moving core PHR upstream into AccessOne clients. Per usual, provider client adds, revenue per AHSC, and mix of organic/inorganic growth heading into FY27 will also be areas of focus on the call. With shares trading at 2.3x consensus FY27 rev. estimates, we believe the risk/reward remains attractive for investors at current levels.
Barclays
$26
Buy
62.09%
Upside
Initiated
12/08/25
BMO Capital
$32
Buy
99.50%
Upside
Assigned
12/02/25
KeyBanc
$35→$32
Buy
99.50%
Upside
Reiterated
10/08/25
Citizens JMP
$30→$34
Buy
111.97%
Upside
Reiterated
09/08/25
Raymond James
$30→$33
Buy
105.74%
Upside
Reiterated
09/05/25
Phreesia's Strong Financial Performance and Strategic Growth Initiatives Drive Buy RatingWe reiterate our Outperform rating and increase our price target to $33 (+$3) on shares of PHR following a modest beat in F2Q26, as the company reported revenue of $117.3M (Street: $116.5M, $116.3M) with strength across network solutions (+24.7% y/y), subscription (+10.5%) and payments (+12.2%). Adj. EBITDA of $22.1M was slightly above expectations (Street: $20.0M, $20.5M) benefiting from lower-than-expected S&M expense ($25.4M vs. $30.4M) and G&A ($19.0M vs. $19.4M), partially offset by higher R&D investment ($29.3M vs. $28.2M). Management reiterated its FY26 revenue outlook of $472–482M and raised its adj. EBITDA guide to $87–92M ($2M midpoint increase) reflecting continued operating leverage.
Piper Sandler
$33→$34
Buy
111.97%
Upside
Reiterated
09/05/25
Best Analysts Covering Phreesia
1 Month
xxx
Success Rate
8/12 ratings generated profit
Average Return
+0.92%
reiterated a xxx
rating 5 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 66.67% of your transactions generating a profit, with an average return of +0.92% per trade.
3 Months
xxx
Success Rate
9/16 ratings generated profit
Average Return
+0.33%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 56.25% of your transactions generating a profit, with an average return of +0.33% per trade.
1 Year
Success Rate
7/15 ratings generated profit
Average Return
-6.57%
reiterated a buy rating 3 days ago
Copying Jailendra Singh's trades and holding each position for 1 Year would result in 46.67% of your transactions generating a profit, with an average return of -6.57% per trade.
2 Years
xxx
Success Rate
3/12 ratings generated profit
Average Return
-21.97%
reiterated a xxx
rating 5 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 25.00% of your transactions generating a profit, with an average return of -21.97% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
PHR Analyst Recommendation Trends
Rating
Aug 25
Sep 25
Oct 25
Nov 25
Dec 25
Strong Buy
0
1
1
1
11
Buy
10
18
18
14
6
Hold
3
2
4
4
6
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
13
21
23
19
23
Each month's total comprises the sum of three months' worth of ratings.
PHR Financial Forecast
PHR Stock Forecast FAQ
What is PHR’s average 12-month price target, according to analysts?
Based on analyst ratings, Phreesia’s 12-month average price target is 30.27.
What is PHR’s upside potential, based on the analysts’ average price target?
Phreesia has 88.72% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is PHR a Buy, Sell or Hold?
Phreesia has a consensus rating of Strong Buy which is based on 12 buy ratings, 0 hold ratings and 0 sell ratings.
What is Phreesia’s price target?
The average price target for Phreesia is 30.27. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $35.00 ,the lowest forecast is $25.00. The average price target represents 88.72% Increase from the current price of $16.04.
The highest analyst price target is $35.00 ,the lowest forecast is $25.00. The average price target represents 88.72% Increase from the current price of $16.04.
What do analysts say about Phreesia?
Phreesia’s analyst rating consensus is a Strong Buy. This is based on the ratings of 12 Wall Streets Analysts.
How can I buy shares of PHR?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.